<table border="1"><tr><th>Type</th><td><ul><li> (NYSE: LLY)</li></ul></td></tr><tr><th>ISIN</th><td><ul><li> US5324571083</li></ul></td></tr><tr><th>Industry</th><td><ul><li> Pharmaceuticals, | Health</li></ul></td></tr><tr><th>Legal form</th><td><ul><li> partnership by shares</li></ul></td></tr><tr><th>Foundation</th><td><ul><li>1876</li></ul></td></tr><tr><th>Founder</th><td><ul><li> Eli Lilly</li></ul></td></tr><tr><th>Headquarters</th><td><ul><li> Indianapolis, Indiana, | United States</li></ul></td></tr><tr><th>Key people</th><td><ul><li>Sidney Taurel, Chairman | John C. Lechleiter, President &amp; CEO | Derica Rice, CFO | founder = Eli Lilly</li></ul></td></tr><tr><th>Products</th><td><ul><li> Prozac, | Humalog, | Cialis, | Strattera, | Darvocet</li></ul></td></tr><tr><th>Income</th><td><ul><li>US$ 21.8 billion | (FY 2009)</li></ul></td></tr><tr><th>Operating profit</th><td><ul><li>US$ 5,660 million | (FY 2009)</li></ul></td></tr><tr><th>Net profit</th><td><ul><li>US$ 4,330 million | (FY 2009)</li></ul></td></tr><tr><th>Assets</th><td><ul><li>US$ 27.5 billion | (FY 2009)</li></ul></td></tr><tr><th>Share capital</th><td><ul><li>US$ 9,520 million | (FY 2009)</li></ul></td></tr><tr><th>Employees</th><td><ul><li>40.600 | (2007)</li></ul></td></tr><tr><th>Branches</th><td><ul><li> Eli Lilly (United Kingdom) | Eli Lilly (Canada) | Eli Lilly (Germany) | Eli Lilly (Singapore) | Eli Lilly (India) | Lilly (China) | Eli Lilly (Italy) | Lilly France</li></ul></td></tr><tr><th>Website</th><td><ul><li> www.lilly.com</li></ul></td></tr></table>